Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Valens Company Inc (The) Ordinary Shares VLNCF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
The Valens Co Inc is a developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are Tinctures, Capsules, Beverages, and Vape cartridges among others. Its reportable segments are Cannabis operations, Analytical testing, and Corporate. The company has a business presence in Canada... see more

Recent & Breaking News (OTCQX:VLNCF)

Valens Signs Multi-year Cannabis Extraction Agreement with Canopy Growth

Canada NewsWire December 13, 2018

Canopy Growth announces multi-year extraction agreement with Valens GroWorks

Canada NewsWire December 13, 2018

Valens expands research collaboration with Thermo Fisher Scientific

Canada NewsWire November 29, 2018

Valens GroWorks Focused on the (Near) Future of the Cannabis Industry -- CFN Media

GlobeNewswire November 26, 2018

Valens Signs Multi-Year Cannabis Extraction and Product R&D Agreement With Harvest One

Canada NewsWire November 14, 2018

Valens Finalizes Listing on the OTCQB

Canada NewsWire November 13, 2018

Valens Receives Updated Health Canada License, Permits B2B Sales

PR Newswire November 12, 2018

Valens Signs Multi-Year Cannabis Extraction Agreement with GTEC Holdings

Canada NewsWire November 5, 2018

Valens Launches Valens Labs and Sells Supra to Australian Based RotoGro for $11,000,000

Canada NewsWire October 29, 2018

Valens announces formation of advisory board

Canada NewsWire October 18, 2018

New Cannabis Standard: Consistent Dosing, Reliable Potency

Jonathon Brown October 17, 2018

Valens Secures ACMPR License to Produce Cannabis Oil

Stockhouse Editorial October 15, 2018

Valens Receives ACMPR License From Health Canada

PR Newswire October 15, 2018

Valens GroWorks Announces Closing of $27.3 Million Bought Deal Financing

Newsfile October 10, 2018

Valens Announces Annual and Special Meeting Results

Canada NewsWire October 5, 2018

An Industry Leader in Cannabis Extraction

Stockhouse Editorial October 2, 2018

Valens Secures Exclusive Rights For IP & Beverage Brands With Tarukino Holdings

Featured Press Release October 1, 2018

Valens Secures Exclusive Rights For IP & Beverage Brands With Tarukino Holdings Inc.

PR Newswire October 1, 2018

BC Cannabis Industry Will Remain a Key Part of the Cannabis World

Investing News Network September 28, 2018

IIROC Trading Resumption - VGW

Canada NewsWire September 18, 2018